Rating Change
Keybanc analysts reiterated a Overweight rating on Omnicell, Inc. (NASDAQ:OMCL) on July 31, 2026.
reiterateNASDAQ:OMCL
Keybanc Reiterates Overweight Rating on Omnicell, Inc. (OMCL)
Rating Change Keybanc analysts reiterated a Overweight rating on Omnicell, Inc. (NASDAQ:OMCL) on July 31, 2026. Market Context Omnicell, Inc.
Market Context
Omnicell, Inc. operates in the Healthcare sector. The stock currently trades at $35.37 with a market capitalization of $2.0B.
Analyst coverage from Keybanc provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Omnicell, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Omnicell, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 31, 2026 | Wells Fargo | Overweight | N/A |
| Jul 31, 2026 | Keybanc | Overweight | N/A |
| Apr 29, 2026 | Keybanc | Overweight | N/A |
| Apr 23, 2026 | Wells Fargo | Overweight | N/A |
| Feb 06, 2026 | Piper Sandler | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View OMCL Stock Page
Frequently Asked Questions
What does a Overweight rating mean for OMCL?
A Overweight rating from Keybanc reflects the analyst's outlook on Omnicell, Inc. (NASDAQ:OMCL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OMCL forecast page.